{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:40:04Z","timestamp":1760611204611,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2786,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.rmed.2005.08.023","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T07:09:17Z","timestamp":1129100957000},"page":"1485-1493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of formoterol after cumulative dosing via Easyhaler\u00ae and Aerolizer\u00ae"],"prefix":"10.1016","volume":"99","author":[{"given":"J.","family":"Randell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saarinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Walamies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Silvasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00e4helm\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2005.08.023_bib1","unstructured":"National Asthma Education and Prevention Program. Expert Panel Report II. Guidelines for the diagnosis and management of asthma, National Institutes of Health, Bethesda, MD, 1997."},{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2005.08.023_bib2","first-page":"i1","article-title":"British guideline on the management of asthma","volume":"58","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.08.023_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00003495-199447020-00001","article-title":"Long- versus short-acting \u03b22-agonists. Implication for drug therapy","volume":"47","author":"Boulet","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2005.08.023_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199142010-00007","article-title":"Formoterol: a review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease","volume":"42","author":"Faulds","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2005.08.023_bib5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1183\/09031936.96.09081684","article-title":"Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action","volume":"9","author":"van Noord","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.08.023_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003495-199855020-00016","article-title":"Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma","volume":"55","author":"Bartow","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2005.08.023_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.93.06020204","article-title":"A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol","volume":"6","author":"Bremner","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.08.023_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1183\/09031936.97.10092105","article-title":"Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer\u00ae","volume":"10","author":"Nielsen","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.08.023_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03259089","article-title":"Delivery devices for inhaled asthma medication. Clinical implications of differences in effectiveness","volume":"6","author":"Selroos","year":"1996","journal-title":"Clin Immunother"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2005.08.023_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.rmed.2004.07.009","article-title":"The size of the problem of managing asthma","volume":"98","author":"Barnes","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/02786829408959751","article-title":"Easyhaler\u00ae multiple dose powder inhaler\u2014practical and effective alternative to the pressurized MDI","volume":"22","author":"Vidgren","year":"1995","journal-title":"Aerosol Sci Technol"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2005.08.023_bib12","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.rmed.2004.07.014","article-title":"How to achieve good compliance with inhaled asthma therapy","volume":"98","author":"Crompton","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib13","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1018902830192","article-title":"Pulmonary deposition and clinical response of 99mTc-labelled salbutamol delivered from a novel multiple dose powder inhaler","volume":"11","author":"Vidgren","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.rmed.2005.08.023_bib14","first-page":"29","article-title":"Pulmonary deposition of 99mTc-labelled salbutamol particles in healthy volunteers after inhalation from a metered-dose inhaler and from a novel multiple-dose powder inhaler","volume":"4","author":"Vidgren","year":"1994","journal-title":"STP Pharm Sci"},{"key":"10.1016\/j.rmed.2005.08.023_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/rmed.2001.1107","article-title":"A comparison of the lung deposition of budesonide from Easyhaler\u00ae, Turbuhaler\u00ae and pMDI plus spacer in asthmatic patients","volume":"95","author":"Hirst","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/rmed.2000.0959","article-title":"Efficacy of salbutamol via Easyhaler\u00ae unaffected by low inspiratory flow","volume":"94","author":"Koskela","year":"2000","journal-title":"Respir Med"},{"year":"2003","series-title":"Design and analysis of cross-over trials","author":"Jones","key":"10.1016\/j.rmed.2005.08.023_bib17"},{"key":"10.1016\/j.rmed.2005.08.023_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thorax.55.8.650","article-title":"Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects","volume":"55","author":"Guhan","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.08.023_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.306.6877.543","article-title":"Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma","volume":"306","author":"Smyth","year":"1993","journal-title":"Br Med J"},{"key":"10.1016\/j.rmed.2005.08.023_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1113\/jphysiol.1977.sp011958","article-title":"The effect of catecholamines on Na\u2013K transport and membrane potential in rat soleus muscle","volume":"270","author":"Clausen","year":"1977","journal-title":"J Physiol"},{"key":"10.1016\/j.rmed.2005.08.023_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s002280050435","article-title":"The extrapulmonary effects of increasing doses of formoterol in patients with asthma","volume":"54","author":"Burgess","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.08.023_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1164\/ajrccm.160.1.9901063","article-title":"Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients","volume":"160","author":"Palmqvist","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib23","first-page":"412","article-title":"Similar bronchodilatation with formoterol delivered by Aerolizer or Turbuhaler","volume":"6","author":"L\u00f6tvall","year":"1999","journal-title":"Can Respir J"},{"key":"10.1016\/j.rmed.2005.08.023_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/thx.47.1.30","article-title":"Time course of bronchodilating effect of inhaled formoterol, a potent and long-acting sympathomimetic","volume":"47","author":"Derom","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.08.023_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/thx.48.6.611","article-title":"Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma","volume":"48","author":"Wallin","year":"1993","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.08.023_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/rmed.2001.1157","article-title":"Assessment of the systemic effects of budesonide inhaled from Easyhaler\u00ae and from Turbuhaler\u00ae in healthy male volunteers","volume":"95","author":"H\u00e4m\u00e4l\u00e4inen","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/rmed.2002.1311","article-title":"Comparison of two budesonide powder inhalers, Easyhaler\u00ae and Turbuhaler\u00ae, in steroid\u2014na\u00efve asthmatic patients","volume":"96","author":"Schweisfurth","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/089426804322994424","article-title":"Comparison of two budesonide dry powder inhalers in the treatment of asthma in children","volume":"17","author":"Vanto","year":"2004","journal-title":"J Aersol Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00044011-200222120-00003","article-title":"Comparison of Easyhaler\u00ae metered-dose, dry powder inhaler and a pressurised metered-dose inhaler plus spacer in the treatment of asthma in children","volume":"22","author":"Juntunen-Backman","year":"2002","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.rmed.2005.08.023_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-3038.1999.101002.x","article-title":"Application and efficacy of the multi-dose powder inhaler, Easyhaler\u00ae, in children with asthma","volume":"10","author":"Malmstr\u00f6m","year":"1999","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.rmed.2005.08.023_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1053\/rmed.2000.0919","article-title":"Salbutamol via Easyhaler\u00ae is at least as effective as salbutamol via Turbuhaler\u00ae in the treatment of histamine-induced bronchoconstriction","volume":"94","author":"Zetterstr\u00f6m","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2005.08.023_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2000.tb11925.x","article-title":"Beclomethasone dipropionate Easyhaler\u00ae is as effective as budesonide Turbohaler\u00ae in the control of asthma and is preferred by patients","volume":"54","author":"J\u00e4ger","year":"2000","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rmed.2005.08.023_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000029467","article-title":"Therapeutic equivalence and acceptability of two multidose powder inhalers in the treatment of asthma","volume":"67","author":"Wettengel","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2005.08.023_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000029486","article-title":"Equivalence of two steroid-containing inhalers: Easyhaler multidose powder inhaler compared with conventional aerosol with large-volume spacer","volume":"67","author":"Koskela","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2005.08.023_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0300-2896(04)75484-8","article-title":"Patient preference in the choice of dry powder inhalers","volume":"40","author":"Giner","year":"2004","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.rmed.2005.08.023_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0011-393X(00)88529-X","article-title":"Patient satisfaction with Easyhaler\u00ae compared with other inhalation systems in the treatment of asthma: a meta-analysis","volume":"61","author":"Ahonen","year":"2000","journal-title":"Curr Ther Res Clin Exp"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611105003586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611105003586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:37Z","timestamp":1760609677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611105003586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0954611105003586"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2005.08.023","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of formoterol after cumulative dosing via Easyhaler\u00ae and Aerolizer\u00ae","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2005.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}